Shaanxi Meibang Pharmaceutical Group Co., Ltd. (605033.SS) Cash and Short-Term Investments

Shaanxi Meibang Pharmaceutical Group Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 67.77 M

Shaanxi Meibang Pharmaceutical Group Co., Ltd. Cash and Short-Term Investments is USD 67.77 M for the year ending December 31, 2023, a 17.46% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Shaanxi Meibang Pharmaceutical Group Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 57.70 M, a -8.89% change year over year.
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 63.33 M, a 107.29% change year over year.
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 30.55 M, a -3.18% change year over year.
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 31.55 M, a 208.86% change year over year.

CEO	Mr. Tong Zhang
IPO Date	Sept. 16, 2021
Location	China
Headquarters	High-tech Industrial Development Zone
Employees	939
Sector	Consumers Staples
Industries Cleaning Supplies Cosmetics Fertilizers Organic Foods Personal Care Pharmaceuticals Plastics Pollution Treatment

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Shanghai Stock Exchange 605033.SS

Shaanxi Meibang Pharmaceutical Group Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 67.77 M

Don’t Miss A Beat

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Description